Steven M. Pollard

10.1k total citations · 2 hit papers
99 papers, 5.9k citations indexed

About

Steven M. Pollard is a scholar working on Molecular Biology, Genetics and Developmental Neuroscience. According to data from OpenAlex, Steven M. Pollard has authored 99 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Molecular Biology, 25 papers in Genetics and 22 papers in Developmental Neuroscience. Recurrent topics in Steven M. Pollard's work include Pluripotent Stem Cells Research (29 papers), Glioma Diagnosis and Treatment (24 papers) and Neurogenesis and neuroplasticity mechanisms (22 papers). Steven M. Pollard is often cited by papers focused on Pluripotent Stem Cells Research (29 papers), Glioma Diagnosis and Treatment (24 papers) and Neurogenesis and neuroplasticity mechanisms (22 papers). Steven M. Pollard collaborates with scholars based in United Kingdom, United States and Italy. Steven M. Pollard's co-authors include Austin Smith, Yirui Sun, Luciano Conti, Stefan H. Stricker, Elena Cattaneo, Mauro Toselli, Gerardo Biella, Peter B. Dirks, Davide Danovi and Ian Chambers and has published in prestigious journals such as Nature, Nature Communications and Nature Genetics.

In The Last Decade

Steven M. Pollard

95 papers receiving 5.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Glioma Stem Cell Lines Expanded in Adherent Culture Have Tumor-Specific Phenotypes and Are Suitable for Chemical and Genetic Screens

2009 756 citations Steven M. Pollard, Ian D. Clarke et al. Cell stem cell profile →
Niche-Independent Symmetrical Self-Renewal of a Mammalian Tissue Stem Cell

2005 701 citations Steven M. Pollard, Yirui Sun et al. PLoS Biology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Steven M. Pollard United Kingdom	40	4.3k	1.2k	1.1k	988	860	99	5.9k
Pilar Sánchez‐Gómez Spain	31	4.3k 1.0×	865 0.7×	625 0.6×	775 0.8×	1.4k 1.6×	79	5.9k
Robert J. Wechsler‐Reya United States	38	5.0k 1.2×	1.5k 1.3×	778 0.7×	948 1.0×	1.4k 1.6×	105	6.5k
Qi‐Long Ying United States	28	7.1k 1.7×	821 0.7×	879 0.8×	549 0.6×	443 0.5×	64	8.3k
Tôru Kondo Japan	36	3.5k 0.8×	758 0.7×	1.4k 1.3×	1.2k 1.2×	1.7k 1.9×	88	6.0k
Nadia Dahmane United States	31	3.9k 0.9×	894 0.8×	665 0.6×	543 0.5×	779 0.9×	66	5.3k
Paolo Malatesta Italy	24	2.5k 0.6×	625 0.5×	2.0k 1.8×	909 0.9×	566 0.7×	55	4.1k
Hugo Guerrero‐Cazares United States	36	1.8k 0.4×	1.1k 0.9×	444 0.4×	704 0.7×	554 0.6×	90	3.6k
Guðrún A. Jónsdóttir United States	9	7.5k 1.8×	806 0.7×	381 0.3×	526 0.5×	493 0.6×	10	8.7k
David D. Eisenstat Canada	35	2.5k 0.6×	1.1k 1.0×	1.3k 1.2×	609 0.6×	372 0.4×	105	4.9k
Shulan Tian United States	22	10.8k 2.5×	1.2k 1.0×	491 0.5×	683 0.7×	752 0.9×	53	12.5k

Countries citing papers authored by Steven M. Pollard

Since Specialization

Citations

This map shows the geographic impact of Steven M. Pollard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven M. Pollard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven M. Pollard more than expected).

Fields of papers citing papers by Steven M. Pollard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven M. Pollard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven M. Pollard. The network helps show where Steven M. Pollard may publish in the future.

Co-authorship network of co-authors of Steven M. Pollard

This figure shows the co-authorship network connecting the top 25 collaborators of Steven M. Pollard. A scholar is included among the top collaborators of Steven M. Pollard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven M. Pollard. Steven M. Pollard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Williams, Charles A.C., Dounia Djeghloul, Nicolás Veland, et al.. (2025). SOX2 phosphorylation during mitosis limits genomic damage. Genes & Development. 40(3-4). 185–198.

Dawson, John C., Virginia Álvarez-García, Morwenna Muir, et al.. (2025). FAK modulates glioblastoma stem cell energetics via regulation of glycolysis and glutamine oxidation. Disease Models & Mechanisms. 18(11).

Walters, Adam A., Yau Mun Lim, Revadee Liam‐Or, et al.. (2025). CD47 Knock‐Out Using CRISPR‐Cas9 RNA Lipid Nanocarriers Results in Reduced Mesenchymal Glioblastoma Growth In Vivo. Advanced Science. 12(12). e2407262–e2407262. 5 indexed citations

Walters, Adam A., Pedro M. Costa, Yue Qin, et al.. (2024). RNA lipid nanoparticles as efficient in vivo CRISPR-Cas9 gene editing tool for therapeutic target validation in glioblastoma cancer stem cells. Journal of Controlled Release. 375. 776–787. 12 indexed citations

Damhofer, Helene, Tülin Tatar, Benjamin Southgate, et al.. (2024). TAK1 inhibition leads to RIPK1-dependent apoptosis in immune-activated cancers. Cell Death and Disease. 15(4). 273–273. 6 indexed citations

Pezić, Dubravka, et al.. (2023). The N-terminus of Stag1 is required to repress the 2C program by maintaining rRNA expression and nucleolar integrity. Stem Cell Reports. 18(11). 2154–2173. 4 indexed citations

Cheroni, Cristina, Sebastiano Trattaro, Nicolò Caporale, et al.. (2022). Benchmarking brain organoid recapitulation of fetal corticogenesis. Translational Psychiatry. 12(1). 520–520. 17 indexed citations

Pollard, Steven M., et al.. (2022). Engineering Cancer Selective Virotherapies: Are the Pieces of the Puzzle Falling into Place?. Human Gene Therapy. 33(21-22). 1109–1120. 4 indexed citations

Badodi, Sara, Nicola Pomella, Xinyu Zhang, et al.. (2021). Inositol treatment inhibits medulloblastoma through suppression of epigenetic-driven metabolic adaptation. Nature Communications. 12(1). 2148–2148. 19 indexed citations

10.

Brooks, Lucy, Melanie Clements, Jemima J. Burden, et al.. (2021). The white matter is a pro-differentiative niche for glioblastoma. Nature Communications. 12(1). 2184–2184. 54 indexed citations

11.

Teixeira, Vera, et al.. (2021). Hierarchical reactivation of transcription during mitosis-to-G1 transition by Brn2 and Ascl1 in neural stem cells. Genes & Development. 35(13-14). 1020–1034. 15 indexed citations

12.

Cloos, Paul A., et al.. (2018). The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. Cancer Research. 78(15). 4114–4125. 50 indexed citations

13.

Marqués‐Torrejón, María Ángeles, Ester Gangoso, & Steven M. Pollard. (2017). Modelling glioblastoma tumour-host cell interactions using adult brain organotypic slice co-culture. Disease Models & Mechanisms. 11(2). 43 indexed citations

14.

O’Duibhir, Eoghan, Neil O. Carragher, & Steven M. Pollard. (2016). Accelerating glioblastoma drug discovery: Convergence of patient-derived models, genome editing and phenotypic screening. Molecular and Cellular Neuroscience. 80. 198–207. 19 indexed citations

15.

Ding, Yu, Christopher G. Hubert, Jacob Herman, et al.. (2012). Cancer-Specific Requirement for BUB1B/BUBR1 in Human Brain Tumor Isolates and Genetically Transformed Cells. Cancer Discovery. 3(2). 198–211. 67 indexed citations

16.

Sun, Yirui, Anna Falk, Hu Jin, et al.. (2009). CD133 (Prominin) Negative Human Neural Stem Cells Are Clonogenic and Tripotent. PLoS ONE. 4(5). e5498–e5498. 98 indexed citations

17.

Pollard, Steven M., Ian D. Clarke, Austin Smith, & Peter B. Dirks. (2009). Brain Cancer Stem Cells: A Level Playing Field. Cell stem cell. 5(5). 468–469. 8 indexed citations

18.

Johnson, Rory, Galih Kunarso, Kandhadayar G. Srinivasan, et al.. (2008). REST Regulates Distinct Transcriptional Networks in Embryonic and Neural Stem Cells. PLoS Biology. 6(10). e256–e256. 167 indexed citations

19.

Pollard, Steven M., Richard W. R. Wallbank, Simon R. Tomlinson, Lars Grotewold, & Austin Smith. (2008). Fibroblast growth factor induces a neural stem cell phenotype in foetal forebrain progenitors and during embryonic stem cell differentiation. Molecular and Cellular Neuroscience. 38(3). 393–403. 45 indexed citations

20.

Pollard, Steven M., Maddy Parsons, Makoto Kamei, et al.. (2005). Essential and overlapping roles for laminin α chains in notochord and blood vessel formation. Developmental Biology. 289(1). 64–76. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact